# Candel Therapeutics

> Candel Therapeutics, Inc. (Nasdaq: CADL) is a clinical-stage biopharmaceutical company in
> Needham, Massachusetts developing off-the-shelf multimodal viral immunotherapies for solid
> tumors. Founded as Advantagene. Candel is a therapeutics developer, not a software vendor.

## No API surface

Candel Therapeutics publishes **no public API**. As of 2026-09-09 there is no developer
portal, no API reference, no OpenAPI/AsyncAPI/GraphQL/Protobuf/WSDL contract, no SDK in any
public package registry, no MCP server, no A2A agent card, and no `/.well-known/` document on
any host the company controls. Every contract-discovery path probed on candeltx.com returned
a real HTTP 404. Do not attempt to call an API here; there is nothing to call.

The company's only credentialed surface is a clinical-trial **investigator portal**, reached
through a login on its HubSpot-hosted marketing site. It is for named clinical-trial
investigators, not for programmatic integration.

Note: `advantagene.com`, the company's former domain, is no longer under company control and
now serves unrelated third-party content. Ignore anything found there.

## Company

- [Candel Therapeutics](https://candeltx.com/): Company home.
- [About](https://candeltx.com/about): Company overview and history.
- [Science](https://candeltx.com/science): The two viral immunotherapy platforms.
- [Pipeline](https://candeltx.com/pipeline): Clinical programs and development stage.
- [Leadership](https://candeltx.com/leadership): Executive team and board.
- [Media](https://candeltx.com/media): Press releases and publications.
- [Careers](https://candeltx.com/careers): Open roles.

## Programs

- aglatimagene besadenovec (CAN-2409): replication-defective adenovirus delivered
  intratumorally with a prodrug to induce immunogenic tumor cell death.
- linoserpaturev (CAN-3110): replication-competent oncolytic herpes simplex virus.

## Clinical trials

- [For patients](https://candeltx.com/patients): Active trials and patient information.
- [For providers](https://candeltx.com/providers): Clinical trial information for clinicians.
- [Investigator login](https://candeltx.com/investigator-login): Credentialed investigator portal.
- [Investigator registration](https://candeltx.com/investigator-portal-registration)

## Contact and legal

- [Contact](https://candeltx.com/contact): info@candeltx.com
- [Privacy policy](https://candeltx.com/privacy-policy)
- [Investor relations](https://ir.candeltx.com/): Nasdaq: CADL. Served behind an edge policy
  that refuses non-browser clients.

## Optional

- [Blog](https://candeltx.com/blog): Company blog. An RSS feed is served at
  https://candeltx.com/blog/rss.xml but currently carries no items.

---
generated: 2026-09-09
method: generated
source: apis.yml + live probes of candeltx.com (API Evangelist enrichment pipeline; not published by Candel Therapeutics)